Skip to content
10-Q

Quarterly Report

THERALINK TECHNOLOGIES, INC.

0001493152-23-005641

← back to feed
Filed
Feb 21, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Feb 21, 2023 6.15B sh
Current Liabilities Q1 2022 · Dec 31, 2022 $46.38M
Current Liabilities Q1 2022 · Sep 30, 2022 $3.46M
Total Liabilities Q1 2022 · Dec 31, 2022 $47.55M
Total Liabilities Q1 2022 · Sep 30, 2022 $6.4M
Current Assets Q1 2022 · Dec 31, 2022 $1.38M
Current Assets Q1 2022 · Sep 30, 2022 $646.98K
Total Assets Q1 2022 · Dec 31, 2022 $3.25M
Total Assets Q1 2022 · Sep 30, 2022 $2.6M
Operating Cash Flow Q1 2022 · Dec 31, 2021 −$1.49M
Stockholders Equity Q1 2022 · Dec 31, 2021 −$4.87M
Stockholders Equity Q1 2022 · Sep 30, 2021 −$4.95M
Eps Basic Q1 2022 · Dec 31, 2021 $0.00
Net Income Q1 2022 · Dec 31, 2021 −$1.51M
Operating Income Q1 2022 · Dec 31, 2021 −$1.38M
Gross Profit Q1 2022 · Dec 31, 2021 $35.41K
Cost Of Revenue Q1 2022 · Dec 31, 2021 $43.57K
Revenue Q1 2022 · Dec 31, 2021 $78.98K